Curriculum Vitae

Roger C. Willette, M.D.

Professional
Address:

President/Physician Owner
Advanced Clinical Research Center of Houston
1051 Pineloch Drive, Suite 600
Houston, Texas 77062

Telephone:
Fax:
Email:

(832) 284-4343
(832) 284-4342
rwillette@acrcofhouston.com

Current Position

Principal Investigator/Owner

Licensure:

Medical License, State of Texas

G6771

Board Certifications:

Internal Medicine
Certification # 108784

Education:

1983-1986

Internal Medicine Internship and Residency Program

Baylor College of Medicine Affiliated Residency
Training Program, Houston, TX, USA.

1980-1983

Doctor of Medicine
Baylor College of Medicine

1978-1980

University of Texas at Austin

Austin, Texas

Professional Experience:

1996 Present

Private Practice Internal Medicine

Roger C. Willette, M.D., P.A.
Webster/Houston, Texas
Pineloch Infusion Center
Roger C. Willette, M.D., P.A
Pineloch Wound Care Clinic
Roger C. Willette, M.D., P.A.

2010 Present

Reading Physician for Surgical

Neuromonitoring
NDX Technologies

Sept. 2011 Present

Medical Director, Houston Office of American

Institute of Gastric Banding

Curriculum Vitae Continued

Roger C. Willette, M.D.
Page Two
Professional Experience Continued:
2007 Present

Coastal Diagnostic Services

Houston, Texas

2007 2012

Principal Investigator
Centex Research, Inc.
Houston, Texas

2010 Present

Bay Area Medical Weight Loss Center

Houston, Texas

Mar 2000-2002

Medical Director
Wound Care Program
Specialty Hospital,
Clear Lake, Webster, Texas

Feb 1996 2000

Medical Director
Columbia Clear Lake Center for Wound Care
and Hyperbaric Medicine
Webster, Texas

1993 1995

Hospice Team Physician

Denson Community Hospice
League City, Texas

1994 1995

Chief of Medicine
Columbia Clear Lake Medical Center
Webster, Texas

1989 1996

Private Practice of Internal Medicine

PRW Medical Consultants
Webster, Texas

1988 1989

Private Practice of Internal Medicine

Advanced Health Center
Houston, Texas

1986 -1988

Clinical Instructor of Medicine,

Baylor College of Medicine
Medical Director Ward 206
Houston Veterans Administration Medical Ctr.
Houston, Texas

Curriculum Vitae Continued

Roger C. Willette, M.D.
Page Three
Clinical Investigator Training:ICH Good Clinical Practice for Clinical Trial Sites
March 2012
Clinical Research Experience:
2008 2009

A Randomized, Double-Blind, Placebo-And-Active Controlled, Parallel Arm,

Multicenter Study in Subjects with Third Stage Joint Disease to Compare the
Frequency of Constipation Symptoms in Subjects Treated With Study Drug IR
and Oxycodone IR Using a Bowel Function Patient Dairy (the Study).
Johnson & Johnson, Protocol R33133PA13020

2009 2011

A Phase ll, Randomized, Double-Blind, Multidose, Active-And-Placebo

Controlled, Multicenter, Parallel Group Study of the Analgesic Effects of Study
Drug in Adult Subjects with Chronic Low Back Pain
Pfizer Protocol A4091012.

2010 2011

An Open-Label, Multicenter, Long Term Study of the Safety of Study Drug In

Patients with Chronic Low Back Pain.
Pfizer Protocol A4091039.

2010 2011

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel

Group, Proof of Concept Study of the Analgesic Effects of Study Drug in Adult
Patients with Diabetic Peripheral Neuropathy.
Pfizer Protocol A4061031.

2010 2011

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging

Study Evaluating the Efficacy and Safety of Study Drug for the Treatment of
Moderate to Severe Pain and Other Symptoms Associated with Interstitial
Cystitis ( Bladder Pain Syndrome ).
Pfizer Protocol A4091035.

2010 Present

A Multicenter, Randomized, Double-Blind Study of the Co-Administration of

Study Drug in Patients with Type 2 Diabetes Mellitus Who Have Inadequate
Glycemic Control.
Protocol #MK 0431, 102

2010 Present

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group,

Multicenter Trial to Evaluate the Efficacy and Safety of Study Drug, Flexible
Dose Regimen in Vulnerable Elderly Patients with Symptoms of Overactive
Bladder.
Pfizer Protocol A0221049.

Curriculum Vitae Continued

Roger C. Willette, M.D.
Page Four

2010 Present

A Phase 3, Randomized, Double-Blind Evaluation of the Safety and Efficacy of

Study Drug in Subjects with Acute Coronary Syndrome.
Protocol # CV185068.

2010 Present

A Phase 2b, Repeat Dosing Clinical Trial of Study Drug in Subjects with
Moderate to Severe Diabetic Neuropathy.
Protocol #SB-509-0901.

2010 Present

A Phase 3, Multicenter, Randomized, Open-Label Clinical Trial Comparing the

Efficacy and Safety of a Sitagliptin-Based Treatment Paradigm to a LiraglutideBased Treatment Paradigm in Patients with Type 2 Diabetes Mellitus Who Have
Inadequate Glycemic Control on Metformin Monotherapy.
Protocol #MD-0431.